神経科学抗体・アッセイの世界市場（～2026年）

• 英文タイトル：Global Neuroscience Antibodies and Assays Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03959
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は神経科学抗体・アッセイのグローバル市場について調査・分析したレポートです。種類別（消耗品、機器）市場規模、用途別（製薬・バイオテクノロジー企業、学術・研究所、病院・診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別神経科学抗体・アッセイの競争状況、市場シェア
・世界の神経科学抗体・アッセイ市場：種類別市場規模 2015年-2020年（消耗品、機器）
・世界の神経科学抗体・アッセイ市場：種類別市場規模予測 2021年-2026年（消耗品、機器）
・世界の神経科学抗体・アッセイ市場：用途別市場規模 2015年-2020年（製薬・バイオテクノロジー企業、学術・研究所、病院・診断センター）
・世界の神経科学抗体・アッセイ市場：用途別市場規模予測 2021年-2026年（製薬・バイオテクノロジー企業、学術・研究所、病院・診断センター）
・北米の神経科学抗体・アッセイ市場分析：米国、カナダ
・ヨーロッパの神経科学抗体・アッセイ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの神経科学抗体・アッセイ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の神経科学抗体・アッセイ市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの神経科学抗体・アッセイ市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Thermo Fisher、Abcam、Bio-Rad、Merck、Cell Signaling Technology、Genscript、Rockland Immunochemicals、BioLegend、Santa Cruz Biotechnology、Roche、Siemens
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

The demand for Neuroscience Antibodies and Assays is increasing, due to the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.

Market Analysis and Insights: Global Neuroscience Antibodies and Assays Market
The global Neuroscience Antibodies and Assays market size is projected to reach US$ 2490.1 million by 2026, from US$ 2343.5 million in 2020, at a CAGR of 5.8%% during 2021-2026.

Global Neuroscience Antibodies and Assays Scope and Market Size
Neuroscience Antibodies and Assays market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuroscience Antibodies and Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens

Market segment by Type, the product can be split into
Consumables
Instruments
Market segment by Application, split into
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
1.4 Market by Type
1.4.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Consumables
1.4.3 Instruments
1.5 Market by Application
1.5.1 Global Neuroscience Antibodies and Assays Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 Academic & Research Institutes
1.5.4 Hospitals & Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2015-2026)
2.2 Global Neuroscience Antibodies and Assays Growth Trends by Regions
2.2.1 Neuroscience Antibodies and Assays Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuroscience Antibodies and Assays Historic Market Share by Regions (2015-2020)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuroscience Antibodies and Assays Market Growth Strategy
2.3.6 Primary Interviews with Key Neuroscience Antibodies and Assays Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Market Size
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2015-2020)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.2.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2019
3.3 Neuroscience Antibodies and Assays Key Players Head office and Area Served
3.4 Key Players Neuroscience Antibodies and Assays Product Solution and Service
3.5 Date of Enter into Neuroscience Antibodies and Assays Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2015-2020)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Neuroscience Antibodies and Assays Market Size by Application (2015-2020)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2015-2020)
6.2 Neuroscience Antibodies and Assays Key Players in North America (2019-2020)
6.3 North America Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
6.4 North America Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2015-2020)
7.2 Neuroscience Antibodies and Assays Key Players in Europe (2019-2020)
7.3 Europe Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

8 China
8.1 China Neuroscience Antibodies and Assays Market Size (2015-2020)
8.2 Neuroscience Antibodies and Assays Key Players in China (2019-2020)
8.3 China Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
8.4 China Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

9 Japan
9.1 Japan Neuroscience Antibodies and Assays Market Size (2015-2020)
9.2 Neuroscience Antibodies and Assays Key Players in Japan (2019-2020)
9.3 Japan Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
9.4 Japan Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Neuroscience Antibodies and Assays Market Size (2015-2020)
10.2 Neuroscience Antibodies and Assays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
10.4 Southeast Asia Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

11 India
11.1 India Neuroscience Antibodies and Assays Market Size (2015-2020)
11.2 Neuroscience Antibodies and Assays Key Players in India (2019-2020)
11.3 India Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
11.4 India Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Neuroscience Antibodies and Assays Market Size (2015-2020)
12.2 Neuroscience Antibodies and Assays Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuroscience Antibodies and Assays Market Size by Type (2015-2020)
12.4 Central & South America Neuroscience Antibodies and Assays Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Details
13.1.2 Thermo Fisher Business Overview
13.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
13.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2015-2020))
13.1.5 Thermo Fisher Recent Development
13.2 Abcam
13.2.1 Abcam Company Details
13.2.2 Abcam Business Overview
13.2.3 Abcam Neuroscience Antibodies and Assays Introduction
13.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.2.5 Abcam Recent Development
13.3 Bio-Rad
13.3.1 Bio-Rad Company Details
13.3.2 Bio-Rad Business Overview
13.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
13.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.3.5 Bio-Rad Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Neuroscience Antibodies and Assays Introduction
13.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Cell Signaling Technology
13.5.1 Cell Signaling Technology Company Details
13.5.2 Cell Signaling Technology Business Overview
13.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
13.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.5.5 Cell Signaling Technology Recent Development
13.6 Genscript
13.6.1 Genscript Company Details
13.6.2 Genscript Business Overview
13.6.3 Genscript Neuroscience Antibodies and Assays Introduction
13.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.6.5 Genscript Recent Development
13.7 Rockland Immunochemicals
13.7.1 Rockland Immunochemicals Company Details
13.7.2 Rockland Immunochemicals Business Overview
13.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
13.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.7.5 Rockland Immunochemicals Recent Development
13.8 BioLegend
13.8.1 BioLegend Company Details
13.8.2 BioLegend Business Overview
13.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
13.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.8.5 BioLegend Recent Development
13.9 Santa Cruz Biotechnology
13.9.1 Santa Cruz Biotechnology Company Details
13.9.2 Santa Cruz Biotechnology Business Overview
13.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
13.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.9.5 Santa Cruz Biotechnology Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche Neuroscience Antibodies and Assays Introduction
13.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
13.10.5 Roche Recent Development
13.11 Siemens
10.11.1 Siemens Company Details
10.11.2 Siemens Business Overview
10.11.3 Siemens Neuroscience Antibodies and Assays Introduction
10.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2015-2020)
10.11.5 Siemens Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Neuroscience Antibodies and Assays Key Market Segments
Table 2. Key Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
Table 3. Ranking of Global Top Neuroscience Antibodies and Assays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consumables
Table 6. Key Players of Instruments
Table 7. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Neuroscience Antibodies and Assays Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Neuroscience Antibodies and Assays Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Neuroscience Antibodies and Assays Market Share by Regions (2015-2020)
Table 11. Global Neuroscience Antibodies and Assays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Neuroscience Antibodies and Assays Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Neuroscience Antibodies and Assays Market Growth Strategy
Table 17. Main Points Interviewed from Key Neuroscience Antibodies and Assays Players
Table 18. Global Neuroscience Antibodies and Assays Revenue by Players (2015-2020) (Million US$)
Table 19. Global Neuroscience Antibodies and Assays Market Share by Players (2015-2020)
Table 20. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroscience Antibodies and Assays as of 2019)
Table 21. Global Neuroscience Antibodies and Assays by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuroscience Antibodies and Assays Product Solution and Service
Table 24. Date of Enter into Neuroscience Antibodies and Assays Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 27. Global Neuroscience Antibodies and Assays Market Size Share by Type (2015-2020)
Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2021-2026)
Table 29. Global Neuroscience Antibodies and Assays Market Size Share by Application (2015-2020)
Table 30. Global Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 31. Global Neuroscience Antibodies and Assays Market Size Share by Application (2021-2026)
Table 32. North America Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 34. North America Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 35. North America Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 36. North America Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 37. North America Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 38. Europe Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 40. Europe Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 42. Europe Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 44. China Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 45. China Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 46. China Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 47. China Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 48. China Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 49. China Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 50. Japan Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 52. Japan Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 54. Japan Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 58. Southeast Asia Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 60. Southeast Asia Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 62. India Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 63. India Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 64. India Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 65. India Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 66. India Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 67. India Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Neuroscience Antibodies and Assays Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Neuroscience Antibodies and Assays Market Share (2019-2020)
Table 70. Central & South America Neuroscience Antibodies and Assays Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Neuroscience Antibodies and Assays Market Share by Type (2015-2020)
Table 72. Central & South America Neuroscience Antibodies and Assays Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Neuroscience Antibodies and Assays Market Share by Application (2015-2020)
Table 74. Thermo Fisher Company Details
Table 75. Thermo Fisher Business Overview
Table 76. Thermo Fisher Product
Table 77. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 78. Thermo Fisher Recent Development
Table 79. Abcam Company Details
Table 80. Abcam Business Overview
Table 81. Abcam Product
Table 82. Abcam Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 83. Abcam Recent Development
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Product
Table 87. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 88. Bio-Rad Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Cell Signaling Technology Company Details
Table 95. Cell Signaling Technology Business Overview
Table 96. Cell Signaling Technology Product
Table 97. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 98. Cell Signaling Technology Recent Development
Table 99. Genscript Company Details
Table 100. Genscript Business Overview
Table 101. Genscript Product
Table 102. Genscript Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 103. Genscript Recent Development
Table 104. Rockland Immunochemicals Company Details
Table 105. Rockland Immunochemicals Business Overview
Table 106. Rockland Immunochemicals Product
Table 107. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 108. Rockland Immunochemicals Recent Development
Table 109. BioLegend Business Overview
Table 110. BioLegend Product
Table 111. BioLegend Company Details
Table 112. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 113. BioLegend Recent Development
Table 114. Santa Cruz Biotechnology Company Details
Table 115. Santa Cruz Biotechnology Business Overview
Table 116. Santa Cruz Biotechnology Product
Table 117. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 118. Santa Cruz Biotechnology Recent Development
Table 119. Roche Company Details
Table 120. Roche Business Overview
Table 121. Roche Product
Table 122. Roche Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 123. Roche Recent Development
Table 124. Siemens Company Details
Table 125. Siemens Business Overview
Table 126. Siemens Product
Table 127. Siemens Revenue in Neuroscience Antibodies and Assays Business (2015-2020) (Million US$)
Table 128. Siemens Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroscience Antibodies and Assays Market Share by Type: 2020 VS 2026
Figure 2. Consumables Features
Figure 3. Instruments Features
Figure 4. Global Neuroscience Antibodies and Assays Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Academic & Research Institutes Case Studies
Figure 7. Hospitals & Diagnostic Centers Case Studies
Figure 8. Neuroscience Antibodies and Assays Report Years Considered
Figure 9. Global Neuroscience Antibodies and Assays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neuroscience Antibodies and Assays Market Share by Regions: 2020 VS 2026
Figure 11. Global Neuroscience Antibodies and Assays Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neuroscience Antibodies and Assays Market Share by Players in 2019
Figure 14. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroscience Antibodies and Assays as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2019
Figure 16. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Neuroscience Antibodies and Assays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

細胞生存アッセイの世界市場（～2026年）

Global Cell Viability Assays Market Size, Status and Forecast 2020-2026
MRC2-11QY11311 2020年11月25日 90Pages
当調査資料は細胞生存アッセイのグローバル市場について調査・分析したレポートです。種類別（ヒト細胞、微生物細胞、動物細胞）市場規模、用途別（製薬・バイオ技術企業、学術研究機関、病院・診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

タンパク質アッセイの世界市場（～2026年）

Global Protein Assays Market Size, Status and Forecast 2020-2026
MRC2-11QY04393 2020年11月20日 90Pages
当調査資料はタンパク質アッセイのグローバル市場について調査・分析したレポートです。種類別（色素結合アッセイ、銅イオンベースアッセイ、テストストリップベースアッセイ、その他）市場規模、用途別（医薬品、疾病診断、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

抗酸化能力アッセイの世界市場（～2026年）

Global Antioxidant Capacity Assays Market Size, Status and Forecast 2020-2026
MRC2-11QY10875 2020年11月25日 92Pages
当調査資料は抗酸化能力アッセイのグローバル市場について調査・分析したレポートです。種類別（グルタチオンアッセイ、アスコルビン酸アッセイ、細胞ベース外因性抗酸化アッセイ）市場規模、用途別（製薬・バイオテクノロジー、学術研究所、臨床検査室、委託研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、...

セルベースアッセイの世界市場（～2026年）

Global Cell Based Assays Market Size, Status and Forecast 2020-2026
MRC2-11QY11298 2020年11月25日 93Pages
当調査資料はセルベースアッセイのグローバル市場について調査・分析したレポートです。種類別（試薬、アッセイキット、マイクロプレート）市場規模、用途別（バイオ製薬会社、学術機関、CRO）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓...

HER2抗体の世界市場（～2026年）

Global HER2 Antibodies Market Size, Status and Forecast 2020-2026
MRC2-11QY12175 2020年11月25日 90Pages
当調査資料はHER2抗体のグローバル市場について調査・分析したレポートです。種類別（トラスツズマブ、ラパチニブ、アド-トラスツズマブエムタンシン、ペルツズマブ、エベロリムス）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

診断用特殊抗体の世界市場（～2026年）

Global Diagnostic Specialty Antibodies Market Size, Status and Forecast 2020-2026
MRC2-11QY11641 2020年11月25日 92Pages
当調査資料は診断用特殊抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、組換えポリクローナル抗体）市場規模、用途別（病院、診断研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、...

モノクローナル抗体(mAb)バイオシミラーの世界市場（～2026年）

Global Monoclonal antibodies (mAbs) Biosimilars Market Size, Status and Forecast 2020-2026
MRC2-11QY03843 2020年11月20日 90Pages
当調査資料はモノクローナル抗体(mAb)バイオシミラーのグローバル市場について調査・分析したレポートです。種類別（エリスロポエチン（EPO）、ヒト成長ホルモン（HGH）、顆粒球コロニー刺激因子（G-CSF）、モノクローナル抗体（mAb）、インスリン、インターフェロン（IFN）、その他）市場規模、用途...

治療用組換え抗体・タンパク質の世界市場（～2026年）

Global Recombinant Therapeutic Antibodies and Proteins Market Size, Status and Forecast 2020-2026
MRC2-11QY04472 2020年11月20日 91Pages
当調査資料は治療用組換え抗体・タンパク質のグローバル市場について調査・分析したレポートです。種類別（血漿たんぱく質、融合たんぱく質、モノクローナル抗体、ホルモン、酵素、凝固因子、その他）市場規模、用途別（腫瘍学、血液学、免疫学、内分泌学、感染症、心血管疾患、その他）市場規模、地域別（北米、米国、カナ...

抗体の世界市場（～2026年）

Global Antibodies Market Insights and Forecast to 2026
MRC2-11QY02522 2020年11月20日 110Pages
当調査資料は抗体のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、ポリクローナル抗体、抗体薬物複合体）市場規模、用途別（病院、介護施設、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イ...

癌治療用モノクローナル抗体の世界市場（～2026年）

Global Cancer Monoclonal Antibodies Market Insights and Forecast to 2026
MRC2-11QY03648 2020年11月20日 115Pages
当調査資料は癌治療用モノクローナル抗体のグローバル市場について調査・分析したレポートです。種類別（マウス抗体、キメラ・ヒト化抗体、完全ヒト化抗体、その他）市場規模、用途別（肝臓、乳房、血液、脳、ホジキンリンパ腫・非ホジキンリンパ腫、結腸直腸、白血病、その他）市場規模、地域別（北米、米国、カナダ、ヨー...

細胞生存アッセイの世界市場（～2026年） Cell Viability Assays is a type of technique used for determining viable cells in the culture. Cell Viability Assays asses the efficiency of the cells by measuring markers of cellular activity. The cell viability is used to monitor the response and health of the cells in the culture after treatment …
抗酸化能力アッセイの世界市場（～2026年） Market Analysis and Insights: Global Antioxidant Capacity Assays Market The global Antioxidant Capacity Assays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Antioxidant Capacity Assays Scope and Market Size Antioxida…
セルベースアッセイの世界市場（～2026年） Market Analysis and Insights: Global Cell Based Assays Market The global Cell Based Assays market size is projected to reach US$ 13050 million by 2026, from US$ 12390 million in 2020, at a CAGR of 4.9%% during 2021-2026. Global Cell Based Assays Scope and Market Size Cell Based Assays market is segm…
タンパク質アッセイの世界市場（～2026年） Market Analysis and Insights: Global Protein Assays Market The global Protein Assays market size is projected to reach US$ 1468.2 million by 2026, from US$ 1374.6 million in 2020, at a CAGR of 6.3%% during 2021-2026. Global Protein Assays Scope and Market Size Protein Assays market is segmented by T…
乳癌モノクローナル抗体の世界市場（～2026年） Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…